Clinical Trial Update: NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares a liposomal irinotecan‑based regimen plus targeted therapy to FOLFOX plus targeted therapy as first-line treatment for metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• Liposome-encapsulated irinotecan (liposomal irinotecan) (irinotecan liposomal formulation)
• OXALIPLATIN (Oxaliplatin)
• Targeted therapy

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Metastatic Colorectal Cancer (CRC) | Phase 3 | Status: RECRUITING